- Home
- CRNX vs LGN Comparison
CRNX vs LGN Comparison
Compare CRNX & LGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- LGN
- Stock Information
- Founded
- CRNX 2008
- LGN 1963
- Country
- CRNX United States
- LGN United States
- Employees
- CRNX N/A
- LGN N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- LGN
- Sector
- CRNX Health Care
- LGN
- Exchange
- CRNX Nasdaq
- LGN Nasdaq
- Market Cap
- CRNX 2.8B
- LGN 3.1B
- IPO Year
- CRNX 2018
- LGN 2025
- Fundamental
- Price
- CRNX $41.56
- LGN $33.89
- Analyst Decision
- CRNX Buy
- LGN Buy
- Analyst Count
- CRNX 12
- LGN 11
- Target Price
- CRNX $74.45
- LGN $37.23
- AVG Volume (30 Days)
- CRNX 2.1M
- LGN 814.5K
- Earning Date
- CRNX 11-06-2025
- LGN 11-07-2025
- Dividend Yield
- CRNX N/A
- LGN N/A
- EPS Growth
- CRNX N/A
- LGN N/A
- EPS
- CRNX N/A
- LGN N/A
- Revenue
- CRNX $1,392,000.00
- LGN $2,213,862,000.00
- Revenue This Year
- CRNX $428.87
- LGN N/A
- Revenue Next Year
- CRNX $958.11
- LGN N/A
- P/E Ratio
- CRNX N/A
- LGN N/A
- Revenue Growth
- CRNX 0.51
- LGN 77.61
- 52 Week Low
- CRNX $24.10
- LGN $26.96
- 52 Week High
- CRNX $62.53
- LGN $34.40
- Technical
- Relative Strength Index (RSI)
- CRNX 54.07
- LGN N/A
- Support Level
- CRNX $43.72
- LGN N/A
- Resistance Level
- CRNX $45.95
- LGN N/A
- Average True Range (ATR)
- CRNX 1.78
- LGN 0.00
- MACD
- CRNX -0.37
- LGN 0.00
- Stochastic Oscillator
- CRNX 19.30
- LGN 0.00
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.